Let’s Think for a Minute- Do Respondents Need Time to Deliberate When Undertaking Health State Valuation Exercises?

Published Jul 17, 2013
Perth, Western Australia – Increasingly, economic analyses are being used to make decisions on how to pay for new medicines and health care practices. Measuring and valuing quality of life are key components of economic analysis but, surprisingly, we know little about how valid and reliable these commonly used methods are. There is growing concern that instant responses to a survey question do not reflect people’s preferences as well as considered, reflective responses, and that the sharing of information, experience and deliberation may be a mechanism that allows respondents to make a more considered decision. In the article, “Does the Process of Deliberation Change Individuals’ Health State Valuations? An Exploratory Study Using the Person Trade-Off Technique,” published in Value in Health, Associate Professor Suzanne Robinson (Curtin University) and Professor Stirling Bryan (University of British Columbia), call for a change in approach when conducting valuation work. This study investigated the use of deliberative practices – that is, giving people time to consider and discuss what living life in a particular disease state would be like. The authors wanted to know if, when given an opportunity for deliberation, people changed their responses and consequently, what their views were on the process. The results were surprising: 74% of participants changed their responses following discussion and deliberation. This had an impact on the overall average valuations. The qualitative analysis supports to the notion that individuals need time to construct their preferences and raises concerns over the validity and reliability of current preference elicitation practices. The authors call for more focused research in this area.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Launches New Content on Whole Health

Sep 23, 2025

ISPOR announced that it has launched new website content on whole health, a topic of increasing importance as health systems across the globe grapple with providing the best possible healthcare to patients within constrained budgets.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×